CDH1 polymorphisms and haplotypes in sporadic diffuse and intestinal gastric cancer: A case-control study based on direct sequencing analysis

World Journal of Surgical Oncology

Volumn 12, Issue 1, 2014, Pages

  Chu, Chi Ming ^a   Chen, Cheng Jueng ^b   Chan, De Chuan ^b   Wu, Hurng Sheng ^c   Liu, Yao Chi ^b   Shen, Chen Yang ^d   Chang, Tzu Ming ^e   Yu, Jyh cherng ^b   Harn, Horng Jyh ^f   Yu, Cheng Ping ^b   Yang, Ming Hsin ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^e TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CDH1; Direct sequencing; Haplotypes; Single nucleotide polymorphisms; Sporadic diffuse and intestinal gastric cancer

Indexed keywords

UVOMORULIN; CADHERIN; CDH1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; HAPLOTYPE; HUMAN; HUMAN TISSUE; INTESTINAL GASTRIC CANCER; INTRON; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPORADIC DIFFUSE GASTRIC CANCER; STOMACH CANCER; TAIWANESE; CANCER STAGING; COMPARATIVE STUDY; DNA SEQUENCE; ENZYME IMMUNOASSAY; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; INTESTINE TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84988517528     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-12-80     Document Type: Article

References (28)

1. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991, 251:1451-1455.
2. Takeichi M: Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem 1990, 59:237-252.
3. Grunwald GB: The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr Opin Cell Biol 1993, 5:797-805.
4. Hirohashi S: Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998, 153:333-339.
5. Pignatelli M, Vessey CJ: Adhesion molecules: novel molecular tools in tumor pathology. Hum Pathol 1994, 25:849-856.
6. Bussemakers MJ, van Moorselaar RJ, Giroldi LA, Ichikawa T, Isaacs JT, Takeichi M, Debruyne FM, Schalken JA: Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res 1992, 52:2916-2922.
7. Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, Nojima D, Carroll P, Dahiya R: A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 2000, 60:873-876.
8. Pharoah PDP, Oliveira C, Machado JC, Keller G, Volgelsang H, Laux H, Becker KF, Hahn H, Paproski SM, Brown LA, Caldas C, Huntsman D: CDH1 c-160a promoter polymorphism is not associated with risk of stomach cancer. Int J Cancer 2002, 101:196-197.
9. Park WS, Cho YG, Park JY, Kim CJ, Lee JH, Kim HS, Lee JW, Song YH, Park CH, Park YK, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY: A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 2003, 18:501-504.
10. Lu Y, Xu YC, Shen J, Yu RB, Niu JY, Guo JT, Hu X, Shen HB: E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population. World J Gastroenterol 2005, 11:56-60.
11. Corso G, Berardi A, Marrelli D, Pedrazzani C, Garosi L, Pinto E, Roviello F: CDH1 C-160A promoter polymorphism and gastric cancer risk. Eur J Cancer Prev 2009, 18:46-49.
12. Humar B, Graziano F, Cascinu S, Catalano V, Ruzzo AM, Magnani M, Toro T, Burchill T, Futschik ME, Merriman T, Guilford P: Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002, 21:8192-8195.
13. Medina-Franco H, Ramos-De la Medina A, Vizcaino G, Medina-Franco JL: Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population. Ann Surg Oncol 2007, 14:2246-2249.
14. Al-Moundhri MS, Al-Khanbashi M, Al-Kindi M, Al-Nabhani M, Burney IA, Al-Farsi A, Al-Bahrani B: Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk. World J Gastroenterol 2010, 16:3432-3436.
15. Wu MS, Huang SP, Chang YT, Lin MT, Shun CT, Chang MC, Wang HP, Chen CJ, Lin JT: Association of the-160C ? A promoter polymorphism of Ecadherin gene with gastric carcinoma risk. Cancer 2002, 94:1443-1448.
16. Kuraoka K, Oue N, Yokozaki H, Kitadai Y, Ito R, Nakayama H, Yasui W: Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. Int J Oncol 2003, 23:421-427.
17. de Martinville B, Wyman AR, White R, Francke U: Assignment of first random restriction fragment length polymorphism (RFLP) locus (D14S1) to a region of human chromosome 14. Am J Hum Genet 1982, 34:216-226.
18. Guo LH, Yang RC, Wu R: An improved strategy for rapid direct sequencing of both strands of long DNA molecules cloned in a plasmid. Nucleic Acids Res 1983, 11:5521-5540.
19. National Center for Biotechnology Information: dbSNP Short Genetic Variations (Online Database). Available at http://hapmap.ncbi.nlm.nih.gov/cgi-perl/snp_details_phase3?name=rs16260&source=hapmap28_B36&tmpl=snp_details_phase3 (accessed 03 March 2014).
20. Tanahashi T, Kita M, Kodama T, Sawai N, Yamaoka Y, Mitsufuji S, Katoh F, Imanishi J: Comparison of PCR-restriction fragment length polymorphism analysis and PCR-direct sequencing methods for differentiating Helicobacter pylori ureB gene variants. J Clin Microbiol 2000, 38:165-169.
21. Davis AH, Wang J, Tsang TC, Harris DT: Direct sequencing is more accurate and feasible in detecting single nucleotide polymorphisms than RFLP: using human vascular endothelial growth factor gene as a model. Biol Res Nurs 2007, 9:170-178.
22. Gao L, Nieters A, Brenner H: Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility. Aliment Pharmacol Ther 2008, 28:565-573.
23. Wang GY, Lu CQ, Zhang RM, Hu XH, Luo ZW: The E-cadherin gene polymorphism-160C?A and cancer risk: a HuGE review and metaanalysis of 26 case-control studies. Am J Epidemiol 2008, 167:7-14.
24. Judson R, Stephens JC, Windemuth A: The predictive power of haplotypes in clinical response. Pharmacogenomics 2000, 1:15-26.
25. Laurén P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type of carcinoma. An attempt at histo-clinical classification. Acta Pathol Microbiol Scand 1965, 64:31-49.
26. Bànkfalvi A, Terpe HJ, Breukelmann D, Bier B, Rempe D, Pschadka G, Krech R, Lellè RJ, Boecker W: Immunophenotypic and prognostic analysis of E-cadherin and β-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44. Histopathology 1999, 34:25-34.
27. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F: E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995, 14:6107-6115.
28. Faul F, Erdfelder E, Lang AG, Buchner A: G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191.